B. Schetschorke
6 Papers
B. Schetschorke is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has co-authored 5 publications.
Chat about Author
Papers
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.
Michael Rade,N. Grieb,Ronald Weiss,Jaren Sia,Luise Fischer,Patrick Born,Andreas Boldt,Stephan Fricke,Paul Franz,Jonathan Scolnick,Lakshmi Venkatraman,Stacy Xu,Christina Kloetzer,Simone Heyn,Anne Sophie Kubasch,Ronny Baber,S. Wang,Enrica Bach,Sandra Hoffmann,J. Ussmann,B. Schetschorke,Saskia Hell,Sebastian Schwind,K. Metzeler,Marco Herling,Madlen Jentzsch,G.-N. Franke,Ulrich Sack,Ulrike Köhl,U. Platzbecker,Kristin Reiche,Vladan Vucinic,M. Merz +32 more
TL;DR: This work subjected mononuclear cells isolated from peripheral blood and bone marrow before and after the application of approved B cell maturation antigen-directed CAR T cells to single-cell multiomic analyses to identify markers associated with resistance and early relapse.
9
Stem cell mobilization and autologous stem cell transplantation after bendamustine, prednisone and bortezomib induction in multiple myeloma patients with renal impairment
Stephan Fricke,Su Wang,T. Holzhey,Madlen Holzvogt,Marc Andrea,Vladan Vucinic,Georg-Nikolaus Franke,Simone Heyn,Saskia Hell,B. Schetschorke,Madlen Jentzsch,Sebastian Schwind,Thomas Zehrfeld,Leanthe Braunert,Thomas Edelmann,Cornelia Becker,F. Hoffmann,Kolja Reifenrath,M Schwarz,Andreas Schwarzer,Franziska Flade,D. Hammerschmidt,Markus Scholz,Maximilian Merz,Uwe Platzbecker,Wolfram Pönisch +25 more
TL;DR: In this article , the authors analyzed the efficacy of a BPV induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (MM) patients depending on the severity of renal impairment.
P-212: Quantifying the average treatment effect of single vs. tandem autologous stem cell transplantation in newly diagnosed multiple myeloma using causal inference
N. Grieb,Alexander Oeser,Anne Sophie Kubasch,Song-Yau Wang,Marie von Lilienfeld-Toal,Olaposi Yomade,Annamaria Brioli,Sarah Strobel,Vladan Vucinic,Georg-Nikolaus Franke,Simone Heyn,Saskia Hell,B. Schetschorke,Madlen Jentzsch,Sebastian Schwind,Andreas Hochhaus,Wolfram Pönisch,Thomas Neumuth,Uwe Platzbecker,Maximilian Merz +19 more
Rapid Response to Idecabtagene Vicleucel in a Myeloma Patient Refractory to Multiple Prior Lines of Anti-BCMA Directed Therapies
Maximilian Merz,Vladan Vucinic,Song-Yau Wang,Christina Kloetzer,B. Schetschorke,Jan Sonntag,J. Ussmann,Saskia Hell,Simone Heyn,Sandra Hoffmann,Enrica Bach,Klaus H. Metzeler,Sebastian Schwind,Marco Herling,Madlen Jentzsch,Georg-Nikolaus Franke,Uwe Platzbecker +16 more
TL;DR: In this paper , the authors describe the first case of rapid response to BCMA-directed CAR-T cells (idecabtagene vicleucel; Ide-cel) in a heavily pretreated patient who had already failed two prior lines of anti-BCMA directed therapies.
P1381: early full donor chimerism after flamsa ric based allogeneic hsct but not presence of morphological remission associates with outcomes in r/r aml patients
J. Ussmann,Saskia Hell,B. Schetschorke,G. Friedrich,Christian Pfrepper,Sebastian Schwind,Madlen Jentzsch,Vladan Vucinic,Marco Herling,Uwe Platzbecker,Georg-Nikolaus Franke +10 more
TL;DR: This retrospective analysis aimed to retrospectively analyze the outcome of 82 consecutive pts with r/r AML who underwent FLAMSA RIC based HSCT between 2006 and 2020 at the center.